Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F W Rath

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
Scandinavian Journal of Gastroenterology|December 17, 1997
Detection of p53 autoantibodies in sera of gastric cancer patients and their prognostic relevanceP Würl, F Weigmann, A Meye, et al.
Cancer Letters|July 8, 1999
Clinical relevance of pRb and p53 co-overexpression in soft tissue sarcomasP Würl, A Meye, C Lautenschläger, et al.
International Journal of Cancer|April 6, 2001
Loss of G2/M arrest correlates with radiosensitization in two human sarcoma cell lines with mutant p53M Bache, S Pigorsch, J Dunst, et al.
International Journal of Radiation Oncology, Biology, Physics|June 29, 2001
Tumor hypoxia, p53, and prognosis in cervical cancersG Haensgen, U Krause, A Becker, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 24, 2001
[Association between elevated serum VEGF and polarographically measured tumor hypoxia in head and neck carcinomas]A Becker, P Stadler, U Krause, et al.
Cancer Genetics and Cytogenetics|January 15, 1998
Cytogenetic characterization of ten malignant fibrous histiocytomasH Schmidt, S Körber, R Hinze, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|March 30, 1999
[p53 overexpression as independent prognostic marker in soft tissue sarcomas is antibody dependent]P Würl, H Taubert, A Meye, et al.
Anticancer Research|May 6, 1998
The p53 gene in soft tissue sarcomas: prognostic value of DNA sequencing versus immunohistochemistryH Taubert, P Würl, M Bache, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 18, 1998
p53 status in radiation-induced soft-tissue sarcomasH Taubert, A Meye, M Bache, et al.
Cancer Letters|March 7, 1998
How is the mutational status for tumor suppressors p53 and p16(INK4A) in MFH of the bone?H Taubert, D Berger, R Hinze, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Scandinavian Journal of Gastroenterology|December 17, 1997
Detection of p53 autoantibodies in sera of gastric cancer patients and their prognostic relevanceP Würl, F Weigmann, A Meye, et al.
Cancer Letters|July 8, 1999
Clinical relevance of pRb and p53 co-overexpression in soft tissue sarcomasP Würl, A Meye, C Lautenschläger, et al.
International Journal of Cancer|April 6, 2001
Loss of G2/M arrest correlates with radiosensitization in two human sarcoma cell lines with mutant p53M Bache, S Pigorsch, J Dunst, et al.
International Journal of Radiation Oncology, Biology, Physics|June 29, 2001
Tumor hypoxia, p53, and prognosis in cervical cancersG Haensgen, U Krause, A Becker, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 24, 2001
[Association between elevated serum VEGF and polarographically measured tumor hypoxia in head and neck carcinomas]A Becker, P Stadler, U Krause, et al.
Cancer Genetics and Cytogenetics|January 15, 1998
Cytogenetic characterization of ten malignant fibrous histiocytomasH Schmidt, S Körber, R Hinze, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|March 30, 1999
[p53 overexpression as independent prognostic marker in soft tissue sarcomas is antibody dependent]P Würl, H Taubert, A Meye, et al.
Anticancer Research|May 6, 1998
The p53 gene in soft tissue sarcomas: prognostic value of DNA sequencing versus immunohistochemistryH Taubert, P Würl, M Bache, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 18, 1998
p53 status in radiation-induced soft-tissue sarcomasH Taubert, A Meye, M Bache, et al.
Cancer Letters|March 7, 1998
How is the mutational status for tumor suppressors p53 and p16(INK4A) in MFH of the bone?H Taubert, D Berger, R Hinze, et al.
Pageof 9